Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic For HIV/AIDS "Sangamo's powerful and precise ZFN-mediated genome editing technology allows us to modify a patient's own stem cells and perform 'autologous' ... (more)
http://ift.tt/1rD3icT
http://ift.tt/1rD3icT
No comments:
Post a Comment